so if insm only gets the $11 million from shire by end of april - how long before investors know about it? Is there going to be a pr about it? insm is always keeping things in the dark and only answer what is asked on the conference calls. and what ever happened to bwd's comments on series A funding for premacure and what happened to the $20 million loan insm took?
lux, premacure has been bought out by Shire, who has the option to pay Insmed by the end of April, or do what they said in their PR by paying future milestones and royalties (IMO what they will do). Insmed took the entire 20 million dollar loan, and I think they are using some of that money to roll-out Arikace production for the Compassionate Use and expected FDA/EMEA approvals.